Member Info for LordSnooty

And now it's back to Roman. Are my eyes deceiving me?

has LSE gone all italic, all of a sudden?

Well I hope it's more than old Snooty's gout that's stirring, this constant draining away of the SP is playing havoc with the extremities.

I haven't a clue what you mean, Chillpots, so spell it out in simple terms for old Snooty please, there's a dear.

Fair enough Chazzy, I just wanted to make the point that this 'fund' is not necessarily in the business of holding to full value, only that there are likely to be points along the way where our esteemed masters decide that now is the time to bank a few quid - and that may come in the short term, out of the blue, as Aphria did.

comments this last week along the lines of this being a long-term hold, implying perhaps that we will be marooned at these levels for some time.
While I agree that the underlying value locked in some of our investees may take years to surface, we should remember that it is not necessarily the intention of our Board to hold individual companies that long; if they see a quick few hundred percent profit, such as happened with Aphria last year, they may well be inclined to take it. In that respect, we have some prime candidates in the series funding rounds, in the potential IPOs, or simply in the investees in which our investment has reached some maturity. In the coming year or so these milestones might tempt our Board to take profit; So I would not agree at all that we are condemned by this current AIM bear market to wallow indefinitely at these levels; a sale of, for example, our Leap interest, could add 50% to our NAV in short order.
The news flow over the past year has been disappointing, but to turn on their heads the words of the caveat posted at the bottom of many investment opportunities, 'past performance is no guarantee of future results'.

Certainlt seems like another roll of the MM dice. Oh well, maybe in May....

What-ho Doggie, all quiet on the Western Front. But where, pray, has the voluble Mr Nob gone?

Agree with your last paragraph but not your second. It's hard to know with a fund-type stock like this which of our investees is going to report what and when, but we are surely well overdue news on a number of them - our Factom investment, the aftermath of the aborted Leap sale, progress on Vemo, further deals for EMMAC, long-awaited update on Yooya....plenty to come this year, any one of which could arrive out of the blue, just as Insilico's FDA news did last week.

a buy!

ODONNELLS - more explicitly, the websites to which you provided the links are robot-generated and maintained. Such pages are often out-of-date, hopelessly inaccurate and no real help in the ever-changing AIM market, particularly with a fund-style stock like FFWD. Thanks anyway.

To be clear, when I said "pathetic", I meant today's SP performance, not anything posted here. To have the SP fall back below where we were before last Friday's RNS merits the word, I think.

is that?

Yes, the figures, if Intensity is bought out, are potentially staggering, even though FFWD owns less than 2% of the company. In rough numbers, every £1bn valuation adds about 12p to the NAV.

Poor market, not a sexy penny stock, flat IR/PR, news slow to arrive, difficult to assess the worth of news like today's - take your pick, but sooner or later a catalyst WILL arrive to make this take off, and the event won't necessarily be signalled. That's old Snooty's view.

http://www.lse.co.uk/share-regulatory-news.asp?shareprice=FFWD&share=fastfwd_innov

Whoops, should have looked before I leaped!

Yesterday's Insilico news was a prime opportunity to publicise it and our great portfolio to the wider world. There is still time today, I suppose - I wonder if we'll get an RNS?

well.

Whether you believe a poster is genuine or not, why not just be civil? Such confrontational posts almost invariably lead to a slanging match, which destroys the equilibrium of the board.